Twenty inpatients suffering from diabetes mellitus were given prescribed therapeutic diets containing 1,000-1,500 kcal/day and supplemented with 28 mg zinc phosphate for 3 weeks. Twenty outpatients were untreated and were advised to consume specified diets. The results indicated good response for the inpatient group. Elevated levels for insulin and serum zinc were shown, which proved to be statistically significant. Blood glucose, glucagon, and glucose-6-phosphatase levels were reduced significantly due to the diet management and zinc supplementation, while calcium showed no difference. The control group did not show any significant difference in any parameter throughout the study. Our findings suggest that a controlled dietary regimen together with supplementation with zinc might be useful to suppress plasma glucose and to regulate insulin secretion of diabetics.
copper and zinc participate in glucose homeostasis in vivo and in vitro by stimulating insulin binding, hexose transport, and lipogenesis.
The effect of zinc administration on serum glucose, insulin, and glucagon as well as on liver glycogen, was investigated in normal adrenalectomized and diabetic rats [4] . It was found from such experiments that the insulin level was significantly increased and that zinc administration may provide a systematic approach to induce glucagon release. Nakamura et al. [5] reported that administration of zinc (200 sag) in the diet of rats for 40 weeks results in a higher insulin level and regulation of the blood glucose level.
Yamaguchi and Takahashi [6] stated that a single oral administration of zinc was sufficient to induce hypocalcemia and caused a decrease in glucose tolerance and insulin secretion in fasted rats. Brange et al. [7] concluded that zinc exerts a tissue-specific stimulation of insulin binding to its receptors.
The studies reported here were designed to determine the effectiveness of dietary zinc supplementation on the pathogenesis of diabetes mellitus, a disease that is a major health problem nowadays..
MATERIALS AND METHODS
This study was conducted on 40 diabetic patients, both males and females between 26 to 62 years of age and with different socioeconomic backgrounds. The patients were chosen from the clinic at Maadi Military Army Hospital. None of the patients showed evidence of any metabolic disorders other than diabetes. The patients were divided into two main groups. The first group comprised 20 inpatients who were given therapeutic diets supplemented with 28 mg zinc phosphate that was added to the diets after cooking. The diets offered to the patients were composed according to the severity of disease and ranged between 1,000-1,500 kcal per day. The food remaining after each meal was reweighed to estimate the actual consumption. Each individual case was followed for at least 3 weeks by determination of the different parameters at the beginning and end of this study.
The second group (20 outpatients) were considered as the control group. They received no zinc supplementation or nutritional education, and were advised to consume diets ranging from 1,000-1,500 kcal per day according to each individual case. They were asked to return to the hospital for two successive months for follow-up of their status and assessment of the biochemical parameters tested.
Dietary intake. Each patient was interviewed to get information related to dietary habits, socioeconomic status, and family history of the disease. A nutritional regimen was then designed for each patient according to his or her recommended caloric-intake.
Biochemical investigations. Venous blood samples were taken at 8 a.m. after overnight 12 h fast at the beginning of the study and after 3 weeks for the inpatient group and monthly for the control group. Analysis for blood glucose was carried out according to Trinder [8] by use of an autoanalyzer RA 1000 (Technicon Instruments, Tarry-town, NY). Plasma insulin was determined with a radioimmunoassay kit obtained from Diagnostic Product Corporation (Los Angeles, CA), and serum glucagon, with a glucagon kit (Radioassay System Laboratories Inc.). Glucose-6-phosphatase was estimated according to Koide and Oda [9] ; and serum calcium, by flame photometry. Plasma zinc was measured by the method of Farag et al. [10] with a Pye Unicam Model Sp 1900 atomic absorption spectrophotometer (Cambridge, England).
Statistical analyses were performed with Student's t-test for paired data.
RESULTS
Dietary intake and diet history The mean daily nutrient intake of subjects investigated before dietary management is presented in Table 1 . The mean energy intake of the control group and inpatients was apparently similar (2,029 and 2,000 kcal, respectively). The mean daily intake of protein was 68 g for the inpatients and 73 g for the outpatients, of which animal protein intake proved to be adequate, being 35 and 32 g, respectively. The most limiting nutrients were zinc and calcium, which had values of 10-11 and 599-605 mg, respectively. Fiber intake, however, seemed to be adequate.
Blood sugar, insulin, glucagon, glucose-6-phosphatase, and mineral levels Data presented in Table 2 summarize the levels of the biochemical parameters investigated for the control and inpatient groups before supplementation. The results indicated no significant difference between the two groups for blood sugar, insulin, glucagon, and glucose-6-phosphatase, all of which were apparently similar. However, the zinc level was higher in the control group (53.90+ 8.06) than in the inpatient one (47.75± 13.20). Mean calcium was found to be 9.08 and 5.75 mg/ dl, respectively. Table 3 illustrates the results obtained for the biochemical measurements in the two groups after dietary management and supplementation with zinc in the inpatient group. There still remained no difference between the groups in terms of Table 1 . Mean of daily dietary intake of different nutrients for the control and inpatient groups.
Val. 12, No. 3, 1992 blood sugar level, whereas the mean insulin level now showed a highly significant difference: 23.92 ,u units/ml for the control vs. 37.35 1u units/ml for the inpatients. Mean glucagon also showed a significant difference (p <0.0005), being 430.35 pg/ ml for the control and 320.00 pg/ml for the zinc treated inpatients. On the other hand, there were no significant differences for glucose-6-phosphatase and calcium levels. As expected the zinc level was significantly increased in the inpatients, being 62.60 a g/dl (vs. 53.99 for the controls). Table 4 . Comparison of mean data of blood sugar, insulin, glucagon, glucose-6-phosphatase, and minerals of control group (starting and after 2 months) (n = 20). Tables 4, 5 summarize the data obtained from the control and inpatient groups at the beginning and the end of the study. For the control group (Table 4) , fasting blood sugar insulin, glucagon, glucose-6-phosphatase as well as calcium and zinc showed no statistically significant changes. While the inpatient group showed differences for the levels of the parameters investigated before and after the dietary management (Table 5) . Elevated levels were shown for insulin and zinc, which proved to be statistically significant. Blood glucose and glucagon, as well as glucose-6-phosphatase, were reduced after the management; and such differences were statistically significant. The calcium level, however, showed no change.
DISCUSSION
In the present study the data given for insulin, glucagon, and glucose-6-phosphatase levels for the control and inpatient groups were approximately similar before zinc supplementation. Their values were 24 p units/ml, 420.15-420.64 pg/ ml, and 3.99-4.19 m-I.U./ml, respectively. Such levels are expected since insulin and glucagon exert dimetrically opposite action on hepatic glucose balance, i.e., glucagon promotes hepatic glucose production, while insulin opposes it. Such findings are in concordance with those reported by Miller [11] , who reported a decreased level for fasting insulin and an elevated one for plasma glucagon among diabetics. Patrick and Tulloch [12] studied the glucose-6-phosphatase activity in patients with diabetes mellitus and found that glucose-6-phosphatase activity was significantly higher in all of them than in non-diabetics. Serum zinc levels (48-54 p g/dl) showed a relative deficiency among the patients, while calcium levels were found to be normal (8.8-9 .0 mg/dl). Such results are in agreement with those reported by Hagglof et al. [13] , Kinlaw et al.
[1], Brange et al. [7] , and Sloane et al. [14] . Gibson et al. [15] observed decreased levels for zinc serum concentration among diabetics (65 ,u g/dl) compared with normal individuals (87 1u g/dl).
Significant changes were shown for the inpatient group after dietary zinc supplementation and dietary management (Tables 3 and 5) , whereas the control group indicated no changes (Table 4) . A significant increase in serum insulin associated with decreased levels for glucagon and glucose-6-phosphatase was observed. A decreased level for serum glucose was also shown. Such observations are in full agreement with those of Martin et al. [16] , and Yamaguchi and Takahashi [6] , who reported that zinc phosphate given to alloxan diabetic dogs resulted in a significant increase in serum insulin associated with decreased values for glucagon and suppression of plasma glucose. However, although Toper et al. [17] found that dietary zinc supplementation resulted in decreased levels for plasma glucose and glucagon, they also noted that fasting plasma insulin was lower in the animals that received the zinc-supplemented diets than in controls. They concluded that the availability of zinc to beta cells may be an important factor in allowing insulin granules to be stored, thus in regulating insulin secretion.
Although our results showed a significant increase in the serum zinc level of the mineral-treated inpatients, some researchers have reported that the serum zinc level is not an absolute index for assessment of zinc status. Davies [18] suggested that measurement of zinc in sweat may be useful adjunct in the clinical assessment of zinc status and may be more sensitive index than either serum or hair zinc levels.
Serum calcium levels indicated no changes after dietary zinc supplementation and showed the normal value both before and after. This finding is in line with the fact that there is no available evidence of calcium deficiency related to diabetes.
In summary, the results of the present study draw attention to the possible importance of zinc supplementation and dietary management in relation to the control of diabetes mellitus.
